The rationale is borrowed from other compounds where tissue saturation and receptor dynamics justify phased dosing
Identidade datos de contacto del responsable del tratamiento La presente Poltica de privacidad se aplica a todos los datos personales tratados por Sensilab d.o.o., con domicilio social en Verovkova 55a, 1000 Liubliana, Eslovenia, nmero de registro mercantil 2113732000, y Vision Healthcare Group, con domicilio social en Grote Markt 41, 8500 Kortrijk, Blgica, nmero de registro mercantil BE 0685.849.188, que actan como corresponsables del tratamiento de conformidad con el Reglamento General de Proteccin de Datos (RGPD) (en lo sucesivo, el responsable del tratamiento)
I know because I spent a decade learning it the hard way
NSL literature pointer PMID 12504925 L-Carnitine laboratory index [PMID: 12504925] National Science Labs indexing note for PMID 12504925: review the PubMed methods, models, and limitations before citing
The FDA recently ordered producers to wind down the compounding of these drugs on the grounds that there were no longer the shortages of the originator drugs that had justified temporary concessions to ensure patients had access to the medications